DGAP-News: Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its First Quarter 2020 Business Update on May 14, 2020
This platform has demonstrated success by developing a novel therapeutic in type 2 diabetes.
DGAP-News: Vivoryon Therapeutics AG / Key word(s): Miscellaneous Vivoryon Therapeutics AG: Vivoryon Therapeutics AG to Publish its First Quarter 2020 Business Update on May 14, 2020 07.05.2020 / 07:00 The issuer is solely responsible for the content of this announcement. Vivoryon Therapeutics AG to Publish its First Quarter 2020 Business Update
07.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Vivoryon Therapeutics AG |
Weinbergweg 22 | |
06120 Halle/Saale | |
Germany | |
Phone: | +49 (0)345 555 9900 |
Fax: | +49 (0)345 555 9901 |
E-mail: | [email protected] |
Internet: | www.vivoryon.com |
ISIN: | DE0007921835 |
WKN: | 792183 |
Listed: | Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; Amsterdam |
EQS News ID: | 1037495 |
End of News | DGAP News Service |
|
1037495 07.05.2020